Core Scientific Rejects $5.75/Share Proposal From CoreWeave; Says Proposal Undervalues Co.
Portfolio Pulse from Benzinga Newsdesk
Core Scientific has rejected a $5.75 per share acquisition proposal from CoreWeave, stating that the offer undervalues the company.
June 06, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Core Scientific has turned down a $5.75 per share acquisition offer from CoreWeave, arguing that the proposal undervalues the company.
The rejection of the acquisition proposal suggests that Core Scientific believes its intrinsic value is higher than the offered price. This could lead to a neutral short-term impact as investors may wait for further developments or a revised offer.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100